Horacio Uri Saragovi

This inventor holds 8 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignees: Mimetogen Pharmaceuticals, Inc, Otonomy, Inc., Aoa Dx. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Horacio Uri Saragovi. Retrieved from https://idiyas.com/inventor/horacio-uri-saragovi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 10)

% Patents Active = 87.5

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

2 out of 10

Mimetogen Pharmaceuticals, Inc

6. 1 out of 834,513

Other

patents

Years Active: 2014-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11786586 - Carbohydrate structures and uses thereof (2023-10-17),

2. 11034961 - Treatment using truncated Trk B and Trk C antagonists (2021-06-15),

3. 10363305 - Anti-ganglioside compound for targeting cancer and generating antibodies (2019-07-30),

4. 10066229 - Treatment using truncated Trk B and Trk C antagonists (2018-09-04),

5. 9707267 - Beta-turn peptidomimetic cyclic compounds for treating dry eye (2017-07-18),

6. 9296691 - Inhibitors of p75 receptor and their uses (2016-03-29),

7. 9200080 - Agonistic antibodies to TrkC receptors and uses thereof (2015-12-01),

8. 8653036 - Methods of treating retinitis pigmentosa (2014-02-18),

Title: Horacio Uri Saragovi: Innovator in Carbohydrate Structures and Therapeutics

Introduction

Horacio Uri Saragovi is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of carbohydrate structures and their applications in immunology and therapeutics. With a total of 8 patents to his name, Saragovi's work has the potential to impact the treatment of various diseases.

Latest Patents

Saragovi's latest patents include innovative methods and compositions related to multivalent carbohydrate antigen structures. These structures are designed to induce immunity against cancer or infection-associated ganglioside carbohydrate antigens. His inventions provide methods for administering these carbohydrate structures to subjects, potentially leading to the development of effective vaccines. Additionally, he has disclosed methods for treating and preventing otic diseases associated with elevated expression levels of truncated TrkC or TrkB isoforms.

Career Highlights

Throughout his career, Horacio Uri Saragovi has worked with notable companies such as Otonomy, Inc. and Mimetogen Pharmaceuticals, Inc. His expertise in carbohydrate structures has positioned him as a key figure in the development of novel therapeutic approaches.

Collaborations

Saragovi has collaborated with esteemed colleagues, including Fabrice Piu and Garth Cumberlidge. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Horacio Uri Saragovi's contributions to the field of carbohydrate structures and therapeutics highlight his role as an influential inventor. His work continues to pave the way for advancements in immunology and treatment methodologies.

Profile summary based on public USPTO records.